Auxilium Pharma (AUXL) Cash Flow Statement

Click line-items for a historical chart and %

Net loss
Stock-based compensation
Depreciation and amortization
Increase in accounts receivable, trade and other	-9.28M
Increase in inventories	-21.4M
Increase in prepaid expenses and current assets	7.26M
Increase (decrease) in accounts payable and accrued expenses	17.25M
Increase in deferred revenue	7.24M
Decrease in deferred rent	-834K
Net cash provided by (used in) operating activities
Purchases of short-term investments	-22.24M
Purchases of property and equipment	-7.47M
Redemptions of long-term investments	0
Net cash used in investing activities
Proceeds from exercise of common stock options	21.27M
Employee Stock Purchase Plan purchases	1.3M
Treasury stock acquisition	-1.03M
Payments in common stock
Net cash provided by financing activities
Effect of exchange rate changes on cash
Decrease in cash and cash equivalents
Cash and cash equivalents, beginning of period	47.75M
Cash and cash equivalents, end of period	74.03M

Entities mentioned with AUXL

View All Entities